Alaunos Therapeutics, Inc. Balance Sheet
TCRT|11 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
Alaunos Therapeutics, Inc. had $3M in total assets and $2M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.4M | $1.1M | $6.1M | $39.1M | $76.1M | $115.1M | $79.7M | $70.9M | $104.7M | $60.4M | $48.8M |
| Current Assets | $2.0M | $2.8M | $8.3M | $53.8M | $78.8M | $130.6M | $105.5M | $84.3M | $70.3M | $80.3M | $106.1M |
| PP&E (Net) | $91.0K | $0 | $2.0K | $8.5M | $10.9M | $10.2M | $1.1M | $1.1M | $801.0K | $2.0M | $1.1M |
| Total Assets | $3.0M | $2.8M | $8.3M | $64.9M | $94.9M | $146.3M | $109.1M | $95.1M | $71.8M | $83.4M | $108.1M |
| Current Liabilities | $813.0K | $692.0K | $2.0M | $24.2M | $16.0M | $18.4M | $12.5M | $9.5M | $7.8M | $18.9M | $13.4M |
| Total Debt | - | - | $0 | $0 | $16.3M | - | - | - | - | - | - |
| Shareholders' Equity | $2.1M | $6.3M | $38.6M | $58.1M | $124.0M | $95.0M | -$96.8M | -$77.3M | $71.6M | $500.0K | $500.0K |